A heteroplasmic mitochondrial DNA 3310 mutation in the ND1 gene in a patient with type 2 diabetes, hypertrophic cardiomyopathy, and mental retardation

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):318-23. doi: 10.1055/s-2005-865646.

Abstract

A mentally retarded 57-year-old Japanese man with maternally-inherited type 2 diabetes was found to have hypertrophic cardiomyopathy (HCM) that was associated with pathological changes in the myocardial mitochondria. The mitochondrial DNA (mtDNA) of this patient was examined and a C3310 T mutation was found in the ND1 gene, which resulted in the substitution of serine for proline. The normal 3310 mtDNA band could not be detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in mtDNA from his myocardium, pancreas, cerebral tissue, skeletal muscle, and lymphocytes. However two clones sequenced from his pancreatic tissue did not show this C3310 T mutation while forty-eight did. Mitochondria isolated from the lymphocytes of his two sisters also had this mutation. mtDNA point mutations in the ND1 gene region reported thus far have been mostly homoplasmic. However, the C3310 T point mutation that was found in this patient was heteroplasmic, which is a high level of mutation and may represent the pathogenic gene that was responsible for causing mitochondrial disease.

Publication types

  • Case Reports

MeSH terms

  • Cardiomyopathy, Hypertrophic / complications*
  • Cardiomyopathy, Hypertrophic / genetics*
  • DNA, Mitochondrial / genetics*
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / genetics*
  • Humans
  • Intellectual Disability / complications*
  • Intellectual Disability / genetics*
  • Male
  • Middle Aged
  • Pedigree
  • Point Mutation*
  • Sequence Analysis, DNA

Substances

  • DNA, Mitochondrial